Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jun 27;14(6):e26374.
doi: 10.7759/cureus.26374. eCollection 2022 Jun.

Early-Onset Drug Hypersensitivity Syndrome in a Man With Pneumonia Due to Pre-sensitization to Olanzapine

Affiliations
Case Reports

Early-Onset Drug Hypersensitivity Syndrome in a Man With Pneumonia Due to Pre-sensitization to Olanzapine

Azusa Sogo et al. Cureus. .

Abstract

Drug hypersensitivity syndrome (DHS) generally starts two weeks to two months after administration of certain drugs. Olanzapine has been reported to cause drug reaction with eosinophilia and systemic symptoms (DRESS), but rarely causes drug-induced hypersensitivity syndrome (DIHS). A 49-year-old schizophrenic man was hospitalized for pneumonia and developed DIHS/DRESS 10 days after starting olanzapine. Although reactivation of human herpesvirus 6, which is one of the diagnostic criteria for DIHS, was not confirmed, the diagnostic criteria for DRESS were met. The patient may have developed early-onset DIHS/DRESS because he was sensitized to olanzapine prior to hospitalization.

Keywords: adverse drug reaction; drug hypersensitivity syndrome; drug-induced hypersensitivity syndrome; olanzapine; skin rash.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Clinical course of the patient’s disease according to body temperature (BT) and the eosinophil count. The red dotted line shows the BT, and the blue line shows the eosinophil count.
BT, body temperature; Eos, eosinophil count; day, days since admission; mPSL, methylprednisolone; PSL, prednisolone; VCM, vancomycin; MEPM, meropenem; LVFX, levofloxacin.
Figure 2
Figure 2. Rash thought to have been caused by olanzapine-induced hypersensitivity. Skin eruption five days (a) and seven days (b), and 16 days (c) after the discontinuation of olanzapine (on days 25, 27, and 36 of hospitalization, respectively). Despite the discontinuation of olanzapine, the skin lesions worsened initially but subsequently resolved following the administration of steroids. Even though skin eruption began to improve on day 34, facial edema and erythema with desquamation of cheeks and periorbital area were still observed on day 36 (c).
Figure 3
Figure 3. Histopathologic findings of skin with no lesion (a) and skin with erythema (b). Findings of interface dermatitis with basal vacuolization, lymphocyte infiltration, and shedding of melanocytes from the basal layer to the dermis layer were observed (b).

References

    1. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Shiohara T, Mizukawa Y. http://Jul. Allergol Int. 2019;68:301–308. - PubMed
    1. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Shiohara T, Inaoka M, Kano Y. Allergol Int. 2006;55:1–8. - PubMed
    1. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Br J Dermatol. 2013;169:1071–1080. - PubMed
    1. Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines. Korekawa A, Nakajima K, Fukushi K, Nakano H, Sawamura D. J Dermatol. 2022;49:652–655. - PMC - PubMed
    1. A case report of olanzapine-induced hypersensitivity syndrome. Raz A, Bergman R, Eilam O, Yungerman T, Hayek T. Am J Med Sci. 2001;321:156–158. - PubMed

Publication types

LinkOut - more resources